» Articles » PMID: 12087009

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2002 Jun 28
PMID 12087009
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine whether the risk of cardiovascular disease (CVD) is elevated before clinical diagnosis of type 2 diabetes in women.

Research Design And Methods: A total of 117,629 female nurses aged 30-55 years who were free of diagnosed CVD at baseline were recruited in 1976 and followed for 20 years.

Results: A total of 1,508 women had diagnosed type 2 diabetes at baseline in 1976. During 20 years of follow-up, 110,227 women remained free of diabetes diagnosis and 5,894 women developed type 2 diabetes. During 2.2 million person-years of follow-up, we documented 1,556 new cases of myocardial infarction (MI), 1,405 strokes, 815 fatal coronary heart disease (CHD), and 300 fatal strokes. Among women who developed type 2 diabetes during follow-up, the age-adjusted RRs of MI were 3.75 (95% CI 3.10-4.53) for the period before the diagnosis and 4.57 (3.87-5.39) for the period after the diagnosis, compared with women who remained free of diabetes diagnosis. The multivariate RRs further adjusting for BMI, smoking, and other cardiovascular risk factors were 3.17 (2.61-3.85) and 3.97 (3.35-4.71). The risk of stroke was also significantly elevated before diagnosis of diabetes (multivariate RR = 2.30 [1.76-2.99]). Further adjustment for history of hypertension or hypercholesterolemia did not appreciably alter the results.

Conclusions: Our data indicate a substantially elevated risk of CVD before clinical diagnosis of type 2 diabetes in women. These findings suggest that aggressive management of cardiovascular risk factors is warranted in individuals at increased risk for diabetes.

Citing Articles

Interventions for Type 2 Diabetes Prevention and Management Among Indigenous Children and Youth: A Systematic Review.

Kanmiki E, Fatima Y, Duong T, Von Senden R, Ushula T, Mamun A Endocrinol Diabetes Metab. 2025; 8(1):e70026.

PMID: 39803793 PMC: 11726261. DOI: 10.1002/edm2.70026.


Phenotyping lipid profiles in type 2 diabetes: Risk association and outcomes from the Cardiovascular Health Study.

Bleich D, Biggs M, Gardin J, Lyles M, Siscovick D, Mukamal K Am J Prev Cardiol. 2024; 19:100725.

PMID: 39286650 PMC: 11402907. DOI: 10.1016/j.ajpc.2024.100725.


The glycosylated hemoglobin level and the severity of cardiovascular involvement in patients with the first episode of acute coronary syndrome.

Khaleghi S, Bayani M, Ziaei N, Salehiomran M, Khafri S Caspian J Intern Med. 2024; 15(1):46-52.

PMID: 38463911 PMC: 10921112. DOI: 10.22088/cjim.15.1.4.


Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study.

Moon J, Kim Y, Oh T, Moon J, Kwak S, Park K Endocrinol Metab (Seoul). 2023; 38(4):406-417.

PMID: 37533176 PMC: 10475965. DOI: 10.3803/EnM.2023.1703.


Incidence of Stroke in People With Diabetes Compared to Those Without Diabetes: A Systematic Review.

Kvitkina T, Narres M, Claessen H, Metzendorf M, Richter B, Icks A Exp Clin Endocrinol Diabetes. 2023; 131(9):476-490.

PMID: 37279879 PMC: 10506631. DOI: 10.1055/a-2106-4732.